
Clarametyx Biosciences
Developer of immune-facilitated biologic therapies designed to fight life-threatening infections. The company's novel technology platform targets the protective barrier around bacteria through biologi...
Valuation
$92M
Latest known
Share Price
N/A
Total Raised
$44M
Last Round
N/A